• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HFpEF 与心房颤动:代谢异常、生物标志物与血管内皮功能障碍的神秘相互作用。

HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction.

机构信息

University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia.

University Medical Centre Ljubljana, Department of Vascular Diseases, Ljubljana, Slovenia.

出版信息

Dis Markers. 2022 Oct 25;2022:9539676. doi: 10.1155/2022/9539676. eCollection 2022.

DOI:10.1155/2022/9539676
PMID:36330203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9626230/
Abstract

BACKGROUND

Heart failure with preserved ejection fraction (HFpEF) has a complex pathophysiology that encompasses systemic proinflammatory state and dysregulated levels of cardiometabolic and oxidative stress biomarkers. The prevalence of both HFpEF and atrial fibrillation (AF) is continuously rising, especially in the elderly. The aim of our study was to explore if there were any differences in biomarker levels and vascular function in the elderly patients with HFpEF with and without AF and to assess interconnections between clinically relevant biomarkers and cardiac and vascular function.

METHODS

This was a cross-sectional study of patients ≥ 65 years with HFpEF who were divided into 2 groups based on the presence or absence of AF. We have sonographically assessed echocardiographic parameters of left ventricular systolic and diastolic function and the peripheral vascular function parameters, namely, pulse wave velocity (PWV) and flow-mediated dilation (FMD). NT-proBNP, irisin, leptin, adiponectin, insulin-like growth factor 1 (IGF-1), and malondialdehyde (MDA) blood levels were determined.

RESULTS

Fifty-two patients (mean age 80 ± 7 years, 67% females) were included. Patients with HFpEF and AF had significantly lower levels of irisin (median 4.75 vs. 13.5 ng/mL, = 0.007), leptin (median 9.5 vs. 15.0 ng/L, = 0.023), and MDA (median 293 vs. 450 ng/mL, = 0.017) and significantly higher values of NT-proBNP (median 2365 vs. 529 ng/L, < 0.001) but not vascular function parameters, as compared to HFpEF patients without AF. MDA was significantly correlated with diastolic function ( = 0.395, = 0.007) and FMD ( = 0.394, = 0.011), while adiponectin was inversely associated with FMD ( = -0.325, = 0.038) and left ventricular ejection fraction ( = -0.319, = 0.029).

CONCLUSIONS

Our results have demonstrated that patients with HFpEF and AF have significantly lower leptin, irisin, and MDA levels compared to patients with HFpEF but without AF. These results offer new insights into the complexity of vascular function and cardiometabolic and oxidative stress biomarkers in the context of HFpEF, AF, and aging.

摘要

背景

射血分数保留的心力衰竭(HFpEF)具有复杂的病理生理学,包括全身促炎状态和代谢及氧化应激生物标志物水平失调。HFpEF 和心房颤动(AF)的患病率都在持续上升,尤其是在老年人中。我们的研究目的是探讨在伴有和不伴有 AF 的老年 HFpEF 患者中,生物标志物水平和血管功能是否存在差异,并评估临床相关生物标志物与心功能和血管功能之间的相互关系。

方法

这是一项横断面研究,纳入了≥ 65 岁的 HFpEF 患者,根据是否存在 AF 将其分为两组。我们通过超声心动图评估了左心室收缩和舒张功能的参数以及外周血管功能参数,即脉搏波速度(PWV)和血流介导的扩张(FMD)。测定了 NT-proBNP、鸢尾素、瘦素、脂联素、胰岛素样生长因子 1(IGF-1)和丙二醛(MDA)的血液水平。

结果

共纳入 52 例患者(平均年龄 80 ± 7 岁,67%为女性)。HFpEF 合并 AF 患者的鸢尾素(中位数 4.75 比 13.5ng/mL, = 0.007)、瘦素(中位数 9.5 比 15.0ng/L, = 0.023)和 MDA(中位数 293 比 450ng/mL, = 0.017)水平显著较低,而 NT-proBNP(中位数 2365 比 529ng/L, < 0.001)水平显著较高,但两组患者的血管功能参数无显著差异。MDA 与舒张功能( = 0.395, = 0.007)和 FMD( = 0.394, = 0.011)显著相关,而脂联素与 FMD( = -0.325, = 0.038)和左心室射血分数( = -0.319, = 0.029)呈负相关。

结论

我们的研究结果表明,HFpEF 合并 AF 患者的瘦素、鸢尾素和 MDA 水平显著低于 HFpEF 但不伴有 AF 的患者。这些结果为 HFpEF、AF 和衰老背景下血管功能和代谢及氧化应激生物标志物的复杂性提供了新的见解。

相似文献

1
HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction.HFpEF 与心房颤动:代谢异常、生物标志物与血管内皮功能障碍的神秘相互作用。
Dis Markers. 2022 Oct 25;2022:9539676. doi: 10.1155/2022/9539676. eCollection 2022.
2
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.应变成像技术评估射血分数保留心力衰竭患者的收缩功能障碍。
J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30.
3
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure and Preserved Ejection Fraction.心力衰竭伴射血分数保留的心房颤动患者的导管消融治疗。
Circ Heart Fail. 2022 Sep;15(9):e009281. doi: 10.1161/CIRCHEARTFAILURE.121.009281. Epub 2022 Jun 21.
4
Is atrial fibrillation in HFpEF a distinct phenotype? Insights from multiparametric MRI and circulating biomarkers.射血分数保留的心力衰竭伴心房颤动是否为一种独特表型?多参数 MRI 和循环生物标志物的研究结果。
BMC Cardiovasc Disord. 2024 Feb 7;24(1):94. doi: 10.1186/s12872-024-03734-0.
5
Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction.射血分数保留的心力衰竭患者舒张功能障碍与N末端B型利钠肽原水平的关联
Mymensingh Med J. 2019 Apr;28(2):333-346.
6
Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).体力活动、生活质量和生物标志物在心房颤动和射血分数保留的心力衰竭中的作用(来自 NEAT-HFpEF 试验)。
Am J Cardiol. 2019 May 15;123(10):1660-1666. doi: 10.1016/j.amjcard.2019.02.025. Epub 2019 Feb 23.
7
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.射血分数保留的心力衰竭中的心房颤动:与运动能力、左心室充盈压、利钠肽和左心房容积的关系。
JACC Heart Fail. 2017 Feb;5(2):92-98. doi: 10.1016/j.jchf.2016.10.005. Epub 2016 Dec 21.
8
Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.心房颤动合并或不合并左心室收缩功能障碍的心力衰竭患者的心房再同步治疗:一项初步研究。
J Interv Card Electrophysiol. 2018 Oct;53(1):9-17. doi: 10.1007/s10840-018-0408-1. Epub 2018 Jul 9.
9
Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF.一氧化氮代谢物:与 HFpEF 患者心血管生物标志物和临床参数的关系。
ESC Heart Fail. 2022 Dec;9(6):3961-3972. doi: 10.1002/ehf2.14116. Epub 2022 Aug 18.
10
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.维生素 D 缺乏症患者的舒张功能障碍或射血分数保留型心力衰竭。
ESC Heart Fail. 2019 Apr;6(2):262-270. doi: 10.1002/ehf2.12413. Epub 2019 Feb 19.

引用本文的文献

1
Oxidative Stress in Postoperative Atrial Fibrillation: Does Malondialdehyde Hold Predictive Value?术后心房颤动中的氧化应激:丙二醛是否具有预测价值?
Medicina (Kaunas). 2025 Apr 22;61(5):778. doi: 10.3390/medicina61050778.
2
Understanding the Role of Irisin in Longevity and Aging: A Narrative Review.了解鸢尾素在长寿和衰老中的作用:一项叙述性综述。
Epidemiologia (Basel). 2025 Jan 8;6(1):1. doi: 10.3390/epidemiologia6010001.
3
New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications.心血管代谢疾病中内皮功能障碍的新见解:潜在机制与临床意义
Int J Mol Sci. 2024 Mar 4;25(5):2973. doi: 10.3390/ijms25052973.
4
Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion.阵发性或持续性心房颤动患者经体外直流电复律后心房颤动复发的生物标志物
Biomedicines. 2023 May 16;11(5):1452. doi: 10.3390/biomedicines11051452.

本文引用的文献

1
Association between adiponectin-to-leptin ratio and heart rate variability in new-onset paroxysmal atrial fibrillation: A retrospective cohort study.脂联素与瘦素比值与新发阵发性心房颤动患者心率变异性的关系:一项回顾性队列研究。
Ann Noninvasive Electrocardiol. 2022 Mar;27(2):e12896. doi: 10.1111/anec.12896. Epub 2021 Oct 2.
2
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
3
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes.糖尿病心力衰竭的流行病学、病理生理学、诊断和治疗。
Diabetes Metab J. 2021 Mar;45(2):146-157. doi: 10.4093/dmj.2020.0282. Epub 2021 Mar 25.
4
Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes.肌肉因子与心力衰竭:在不良心脏重构、心肌病和临床结局方面的挑战性作用。
Dis Markers. 2021 Jan 13;2021:6644631. doi: 10.1155/2021/6644631. eCollection 2021.
5
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg.射血分数保留的心力衰竭病理生理学的潜在机制:冰山一角。
Heart Fail Rev. 2021 May;26(3):453-478. doi: 10.1007/s10741-020-10042-0. Epub 2021 Jan 7.
6
Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.纤维连接蛋白 III 型结构域包含蛋白 5 在心血管和代谢疾病中的作用:一个有前途的生物标志物和治疗靶点。
Acta Pharmacol Sin. 2021 Sep;42(9):1390-1400. doi: 10.1038/s41401-020-00557-5. Epub 2020 Nov 19.
7
Aortic Pulse Wave Velocity, Ankle-Brachial Index, and Malondialdehyde in Older Adults with or without Metabolic Syndrome.患有或未患有代谢综合征的老年人的主动脉脉搏波速度、踝臂指数和丙二醛
Pulse (Basel). 2020 Aug;8(1-2):31-39. doi: 10.1159/000505838. Epub 2020 Feb 11.
8
Metabolic inflammation in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中的代谢炎症。
Cardiovasc Res. 2021 Jan 21;117(2):423-434. doi: 10.1093/cvr/cvaa217.
9
Atrial fibrillation in aging population.老年人群中的心房颤动
Aging Med (Milton). 2018 Apr 23;1(1):67-74. doi: 10.1002/agm2.12015. eCollection 2018 Jun.
10
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭中的微血管功能障碍
Front Physiol. 2019 Nov 5;10:1347. doi: 10.3389/fphys.2019.01347. eCollection 2019.